The image on the left is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using CSB-PA985521(FHL3 Antibody) at dilution 1/40, on the right is treated with fusion protein. (Original magnification: x200)
The image on the left is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using CSB-PA985521(FHL3 Antibody) at dilution 1/40, on the right is treated with fusion protein. (Original magnification: x200)
FHL3 Antibody
CSB-PA985521
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetFHL3
Overview
- SupplierCusabio
- Product NameFHL3 Antibody
- Delivery Days Customer20
- ApplicationsELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID2275
- Target nameFHL3
- Target descriptionfour and a half LIM domains 3
- Target synonymsFHL-3; four and a half LIM domains protein 3; LIM-only protein FHL3; skeletal muscle LIM-protein 2; SLIM2; SLIM-2
- HostRabbit
- IsotypeIgG
- Protein IDQ13643
- Protein NameFour and a half LIM domains protein 3
- Scientific DescriptionThe protein encoded by this gene is a member of a family of proteins containing a four-and-a-half LIM domain, which is a highly conserved double zinc finger motif. The encoded protein has been shown to interact with the cancer developmental regulators SMAD2, SMAD3, and SMAD4, the skeletal muscle myogenesis protein MyoD, and the high-affinity IgE beta chain regulator MZF-1. This protein may be involved in tumor suppression, repression of MyoD expression, and repression of IgE receptor expression. Two transcript variants encoding different isoforms have been found for this gene.
- ReactivityHuman
- Storage Instruction-20°C or -80°C
- UNSPSC12352203